These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
447 related items for PubMed ID: 11095341
21. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. Joo M, Abreu-e-Lima P, Farraye F, Smith T, Swaroop P, Gardner L, Lauwers GY, Odze RD. Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408 [Abstract] [Full Text] [Related]
23. Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C. Hov JR, Lleo A, Selmi C, Woldseth B, Fabris L, Strazzabosco M, Karlsen TH, Invernizzi P. J Hepatol; 2010 May; 52(5):712-7. PubMed ID: 20347497 [Abstract] [Full Text] [Related]
24. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis. Ngu JH, Gearry RB, Wright AJ, Stedman CA. Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1092-7; quiz e135. PubMed ID: 21893134 [Abstract] [Full Text] [Related]
25. Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden. Bergquist A, Said K, Broomé U. Scand J Gastroenterol; 2007 Jan; 42(1):88-93. PubMed ID: 17190768 [Abstract] [Full Text] [Related]
26. Spectrum of autoimmune liver diseases in western India. Amarapurkar DN, Patel ND. J Gastroenterol Hepatol; 2007 Dec; 22(12):2112-7. PubMed ID: 17623034 [Abstract] [Full Text] [Related]
27. Primary sclerosing cholangitis in children: a long-term follow-up study. Feldstein AE, Perrault J, El-Youssif M, Lindor KD, Freese DK, Angulo P. Hepatology; 2003 Jul; 38(1):210-7. PubMed ID: 12830004 [Abstract] [Full Text] [Related]
28. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis. Stallhofer J, Denk GU, Glas J, Laubender RP, Göke B, Rust C, Brand S, Pusl T. Digestion; 2011 Jul; 84(1):29-35. PubMed ID: 21304239 [Abstract] [Full Text] [Related]
29. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease. Navaneethan U, Remzi FH, Nutter B, Fazio VW, Shen B. Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410 [Abstract] [Full Text] [Related]
30. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G. Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):685-91. PubMed ID: 8853259 [Abstract] [Full Text] [Related]
31. Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis. Henckaerts L, Jaspers M, Van Steenbergen W, Vliegen L, Fevery J, Nuytten H, Roskams T, Rutgeerts P, Cassiman JJ, Vermeire S, Cuppens H. J Hepatol; 2009 Jan; 50(1):150-7. PubMed ID: 18992954 [Abstract] [Full Text] [Related]
33. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis. Gallegos-Orozco JF, E Yurk C, Wang N, Rakela J, Charlton MR, Cutting GR, Balan V. Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035 [Abstract] [Full Text] [Related]
34. Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease. Silvain C, Zeevi A, Saidman S, Duquesnoy RJ, Van Thiel DH. Hepatogastroenterology; 1995 Jul; 42(3):250-8. PubMed ID: 7590574 [Abstract] [Full Text] [Related]
35. HLA and autoimmune digestive disease: a clinically oriented review for gastroenterologists. Cassinotti A, Birindelli S, Clerici M, Trabattoni D, Lazzaroni M, Ardizzone S, Colombo R, Rossi E, Porro GB. Am J Gastroenterol; 2009 Jan; 104(1):195-217; quiz 194, 218. PubMed ID: 19098870 [Abstract] [Full Text] [Related]
36. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis. Tischendorf JJ, Meier PN, Strassburg CP, Klempnauer J, Hecker H, Manns MP, Krüger M. Scand J Gastroenterol; 2006 Oct; 41(10):1227-34. PubMed ID: 16990210 [Abstract] [Full Text] [Related]
37. Defining the relationship between autoimmune disease and primary sclerosing cholangitis. Talwalkar JA, LaRusso NF, Lindor KD. Am J Gastroenterol; 2000 Nov; 95(11):3024-6. PubMed ID: 11095312 [No Abstract] [Full Text] [Related]
39. The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS. Am J Gastroenterol; 2007 May; 102(5):1042-9. PubMed ID: 17313496 [Abstract] [Full Text] [Related]
40. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC. Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]